EU pharma legislation – impact on SMEs
In April 2023, the European Commission published new legislative proposals to revise the EU’s long-standing pharmaceutical legislation and ensure it…
The connections between biotechnology, innovation and venture capital are complex. Therefore, we would like to share insights and information with you to give you a better understanding of our position on EU pharma policy developments and the steps we believe to be necessary in order to strengthen the biotech/life sciences sector in Europe and to stay internationally competitive. LSAA is well connected through its partners and advisory board members.
True to our motto “Discover, Invest, Cure”, we closely follow current developments of EU politics with regard to healthcare or the biotech and life sciences sector and provide you with regular insights here. Most of this content is also available on our Youtube channel or on our LinkedIn profile.
Here you can change your privacy preferences.